IL32 and primary cutaneous T-cell non-Hodgkin lymphoma: Different studies have found that IL-32 plays a role in both, the development, and the induction of an immune response in melanoma (Figure 1E) and cutaneous T-cell lymphoma (CTCL, Figure 1F).